🇺🇸 FDA

Drug profile · INN

bempedoic acid

NILEMDO

approved C10B
US status
approved
Patents linked
8
News articles
0

Quick answer

bempedoic acid (NILEMDO) is an FDA-listed pharmaceutical active ingredient. Associated with Esperion Therapeutics. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN bempedoic acid
Brand NILEMDO
Route ORAL
Formulation TABLET
ATC code C10B

Related patents

Search patents →

Frequently asked questions

What is bempedoic acid?

bempedoic acid (NILEMDO) is an FDA-listed pharmaceutical active ingredient. Associated with Esperion Therapeutics. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for bempedoic acid?

NILEMDO is a marketed brand name for bempedoic acid. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of bempedoic acid?

bempedoic acid has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.